I’m Having a Baby — What Happens to My Gout Medication?

You’re trying to get pregnant. Or maybe you’re already pregnant. Either way, you’ve got questions that your doctor probably can’t fully answer: Can I stay on my gout medication while trying to conceive? What if I flare during pregnancy, what can I take? And after the baby comes, what’s safe while breastfeeding?

These aren’t niche concerns. They’re some of the most common questions I hear from women with gout in their 20s, 30s, and early 40s. And the honest answer is: the research here is messier than it should be. But here’s what we actually know.

Why Pregnancy Changes the Gout Equation

Let me back up for a second. If you’re premenopausal and you’ve been managing gout, your body has been working with a natural advantage: estrogen. Estrogen helps your kidneys flush out uric acid more efficiently. During pregnancy, estrogen levels spike dramatically. For some women, this means fewer flares than usual during those nine months.

But here’s the thing: pregnancy also increases your body’s turnover of cells, ramps up metabolism, and changes how your kidneys filter things. The net effect on uric acid isn’t straightforward. Some women actually see their levels rise during pregnancy, especially in the third trimester. And the moment you deliver, estrogen crashes back down. That sudden hormonal shift is a classic gout trigger, which is why many women experience their first-ever attack, or a bad flare, right after giving birth.

So managing gout around pregnancy isn’t just about one moment in time. It’s about the whole arc: trying to conceive, the nine months, delivery, and the breastfeeding phase.

Urate-Lowering Therapy: What the Guidelines Actually Say

Let’s talk about the elephant in the room: allopurinol and febuxostat.

Allopurinol is the most commonly prescribed urate-lowering therapy. It’s generally considered the first-line treatment for gout. But when it comes to pregnancy, the picture gets murky.

The U.S. Food and Drug Administration (FDA) labeling for allopurinol states that it crosses the placenta and may cause fetal harm based on animal data. In rats and rabbits given very high doses, no birth defects showed up. But in one mouse study, very high intraperitoneal doses did cause fetal abnormalities, and that study gets cited a lot, even though the dosing method (intraperitoneal, not oral) doesn’t mirror how humans take it.

Human data is thin. About 50 pregnancies with first-trimester allopurinol exposure have been reported in published literature. Two infants had major birth defects, but so did two infants in the control groups of the same studies. The data doesn’t show a clear pattern of harm, but “no clear pattern” isn’t the same as “completely safe.” Most major guidelines, including British and Malaysian rheumatology guidelines, recommend against using allopurinol during pregnancy unless the mother’s gout is severe enough that NOT treating poses a greater risk.

What does that mean practically? If you’re on allopurinol and you’re planning a pregnancy, talk to your doctor before you stop using contraception. Don’t just quit the medication on your own. Some women with frequent, debilitating flares genuinely need to stay on treatment, and in those cases, the benefit may outweigh an uncertain theoretical risk. But that decision needs to be made with a rheumatologist who knows your full history.

Febuxostat has even less human pregnancy data. The 2024 update of Chinese guidelines for hyperuricemia and gout mentions that febuxostat “may be considered only when the benefits outweigh the potential risks to the fetus,” which is doctor-speak for “we don’t really know, use your judgment.” If you’re on febuxostat and considering pregnancy, this is a conversation you need to have with your rheumatologist sooner rather than later.

Benzbromarone, a urate-lowering drug not commonly used in the US but available elsewhere, is generally not recommended during pregnancy due to animal data suggesting harm.

The Breastfeeding Problem Nobody Talks About Clearly

Okay, so you’ve had the baby. You’re breastfeeding. You’ve got gout. Now what?

Here’s what the data actually shows:

Allopurinol and its active breakdown product, oxypurinol, are both present in human breast milk. There’s a single case report, just one, of a woman taking 300 mg of allopurinol daily at 5 weeks postpartum. Researchers detected both allopurinol and oxypurinol in her breast milk. Based on that one case, the estimated infant dose was small. But the FDA and most regulatory bodies still advise against breastfeeding while taking allopurinol, and recommend waiting at least one week after the last dose before nursing.

The thinking goes: we don’t have enough data to say it’s safe, so the conservative recommendation is to pump and discard milk, or formula feed, during the treatment period.

For febuxostat and benzbromarone, the data is even thinner. Most guidelines essentially say “we don’t know, so don’t do it” out of an abundance of caution.

I want to be honest with you: this is a genuinely hard situation. Some women have such severe gout that going completely off urate-lowering therapy isn’t realistic, especially if they’re nursing for a year or more. If you’re in this position, work with both your rheumatologist and your OB-GYN to find a plan that makes sense for your specific situation. Don’t make decisions in a vacuum, but also don’t feel like you have zero options.

Acute Flares During Pregnancy and Nursing: What Can You Actually Take?

This is where it gets more practical, because an acute flare doesn’t wait for a convenient time.

Colchicine is the most studied option here. Colchicine crosses the placenta, and it’s classified as an FDA former pregnancy category C drug, meaning animal studies showed some risk but human data is limited, but there aren’t enough human studies to be definitive. That said, studies of women using colchicine for familial Mediterranean fever (FMF) during pregnancy, including large case series, suggest that colchicine at standard gout doses isn’t clearly linked to major birth defects or adverse pregnancy outcomes.

Most rheumatologists are more comfortable using colchicine for acute flares during pregnancy than continuing urate-lowering therapy. The thinking is: a short course of colchicine for a flare carries less theoretical risk than maintaining daily urate-lowering drugs throughout pregnancy.

During breastfeeding, colchicine does pass into breast milk. Current guidance is mixed. Some sources say it’s compatible with breastfeeding, others advise caution. The American Academy of Pediatrics has historically noted that colchicine is “compatible with breastfeeding” based on limited data, but the drug’s narrow therapeutic window means dosing matters a lot.

NSAIDs (like ibuprofen) are generally avoided during pregnancy, especially in the third trimester, because they can affect fetal kidney development and close the ductus arteriosus prematurely. First and second trimester use is sometimes permitted under doctor supervision, but NSAIDs aren’t a long-term solution for gout flares during pregnancy.

Corticosteroids (like prednisone) are sometimes used for acute gout flares during pregnancy. Prednisone does cross the placenta, but at typical short-course doses, the amount reaching the fetus is low. Some obstetricians have concerns about long-term or repeated use, but a brief course for a gout flare is generally considered safer than uncontrolled inflammation.

Joint aspiration, draining fluid from the affected joint and analyzing it under a microscope to confirm urate crystals, is considered safe during pregnancy and can be both diagnostic and therapeutic. If your doctor is uncertain whether your joint pain is actually gout, joint aspiration gives a definitive answer without medication exposure.

Non-Drug Strategies That Actually Matter During This Period

Regardless of where you stand on medication, the lifestyle stuff becomes even more important when you’re pregnant or nursing.

Hydration is non-negotiable. Your kidneys are working overtime during pregnancy, and dehydration is a direct trigger for both flares and kidney stones (which pregnant women are already more prone to). Aim for 8 to 10 glasses of water daily if you can, more if you’re breastfeeding.

Purine management through diet still applies. You don’t need to be perfect, but keeping organ meats, certain seafoods (anchovies, sardines, scallops), and excessive alcohol to a minimum helps. Dairy, cherries, and coffee have actual data suggesting mild uric-acid-lowering or anti-inflammatory effects. Worth leaning into during this period.

Watch out for crash dieting. I know the postpartum weight loss pressure is real. But rapid weight loss, the kind where you’re losing more than 1 to 2 pounds per week, mobilizes uric acid from body tissues into your bloodstream and frequently triggers flares. Slow and steady is the only sustainable approach when you have gout.

Review your other medications with your doctor. Some drugs commonly prescribed during pregnancy, notably thiazide diuretics for blood pressure, can raise uric acid levels. If you’ve been on a diuretic and you develop gout, that’s worth mentioning to your OB-GYN. High blood pressure medications and their effects on uric acid are worth understanding if you’re managing both conditions.

Having the Conversation With Your Doctor Before You’re in Crisis

Here’s my advice: don’t wait for a flare to have this conversation. If you’re a woman with gout who might become pregnant, whether you’re actively trying or just not using contraception, have this discussion with your rheumatologist now.

Questions worth bringing up:

• If I’m on urate-lowering therapy, should I stay on it while trying to conceive, or should I stop before getting pregnant?
• What’s our plan if I have a flare during pregnancy? Do you have a preferred treatment?
• Is joint aspiration available if we need a definitive diagnosis during pregnancy?
• What are my options if I have a severe flare while breastfeeding?
• Are there any supplements (like vitamin C) that might help manage uric acid more safely during this period?

Not all rheumatologists are up to speed on the nuances of gout and pregnancy. If yours doesn’t seem to have clear answers, ask for a referral to a maternal-fetal medicine specialist or a second opinion from a rheumatologist who specializes in inflammatory conditions in pregnancy. You’re allowed to advocate for yourself here.

If you’re also dealing with atypical gout symptoms or misdiagnosis concerns, that context is worth bringing into every medical appointment, pregnancy or not.

Frequently Asked Questions

Can I stay on allopurinol while trying to get pregnant?

Guidelines suggest discussing discontinuation with your rheumatologist at least one month before trying to conceive. If you have frequent flares or tophi, your doctor may weigh the risks and benefits of continuing versus stopping during the preconception period. Do not stop medication without medical guidance.

Is colchicine safe during pregnancy?

Colchicine is generally considered relatively safe based on accumulated human data, but crosses the placenta. Most rheumatologists consider it acceptable when needed for acute flares during pregnancy, particularly when uncontrolled inflammation poses greater risk. Always discuss with your obstetrician and rheumatologist.

What can I take for a gout flare while breastfeeding?

Colchicine is considered compatible with breastfeeding by most sources. Prednisone is also generally acceptable. NSAIDs like naproxen or ibuprofen may be options with short half-lives preferred. Timing doses around breastfeeding sessions is worth discussing with your doctor.

Will my baby’s gout risk go up if I have gout?

Gout has genetic components, so there may be some hereditary risk. However, lifestyle and environmental factors also play significant roles. Having gout doesn’t guarantee your child will develop it, but being aware of family history is useful for your child’s future healthcare.

Does pregnancy make gout worse in the long run?

Pregnancy itself doesn’t permanently worsen gout, but hormonal changes during and after pregnancy can affect flare patterns. Some women experience more flares postpartum, particularly when estrogen drops. Long-term management should resume after delivery with your doctor’s guidance.

Should I stop febuxostat if I’m planning pregnancy?

Febuxostat is generally discontinued prior to conception in most protocols. Unlike allopurinol, there is considerably less human data on febuxostat during pregnancy. Most guidelines recommend stopping it and switching to an approach with more established safety data. Discuss switching strategies with your rheumatologist.

Can urate-lowering therapy be started during pregnancy?

Starting urate-lowering therapy during pregnancy is generally not recommended unless the benefits clearly outweigh risks. If you were already on therapy before pregnancy, your doctor may advise continuing, adjusting, or stopping depending on your situation. The safest approach is to have this discussion before conception.

Reviewed by the GoutSavvy Editorial Team